General Medicine and Specialty Medicine Industry Market Research & Statistics

  • Currently 4/5 Stars.
  • 1
  • 2
  • 3
  • 4
  • 5
3 votes

Global General & Specialty Medicine


The medical industry encompasses both general and specialty disciplines. General medicine is concerned with treating chronic and acute diseases through preventive care, curative care and health education.


In comparison, specialty medicine involves the treatment of specific medical conditions and illnesses. Major specialties within this branch of medicine include therapeutic, diagnostic, internal and surgical medicine.







Key Market Segments                                                       


  • The worldwide market for pain management therapeutics was worth almost $20 billion in 2010, according to GBI Research. The market recorded yearly growth in excess of 5% for the eight-year period ending 2010. Lyrica, an anticonvulsant, and Cymbalta, an anti-depressant, represent the leading products on the pain management market. Both are due to expire in 2013. The global pain management therapeutics industry is expected to record yearly growth of 3% between 2010 and 2017 to exceed $35 billion. Market leaders that will continue to fuel market growth include Pfizer’s Remoxy, UCB Group’s Vimpat, J&J’s Nucynta, Orexo’s Abstral and Teva’s Fentora.


  • Leading markets within the pain management therapeutics industry include post-operative pain, low-back pain and cancer pain relief markets. Post-operative pain relief represents the largest segment, reaching almost $6 billion in 2010 or 20% of the overall industry. The post-operative pain relief market was followed by the low-back pain market, which reached almost $5 billion in 2010, for more than 15% of the overall pain management therapeutics market. The cancer pain and neuropathic pain relief markets came third, accounting for a slightly lower percentage of the overall industry than the low-back pain market.


  • The global dermatology market is lead by demand for psoriasis treatment. There are less than 20 million sufferers worldwide, but it accounts for close to 20% of the overall dermatology market, reports Business Insights. The anti-acne market segment is fuelled by combination products, with leading products including Ziana by Medicis, Duac by GSK/Stiefel, and Sanofi’s BenzaClin. Dermatology sales generated $1.3 billion for leading company Leo Pharma in 2010, representing 20% year-on-year growth. The company is forecast to continue recording strong sales with the launch of its actinic keratosis treatment ingenol mebutate.


  • Sports medicine continues to benefit from technological developments. Arthroscopy, a minimally invasive technique has shortened recovery time for athletes. Most procedures are carried out to repair knee damage, reports Koncept Analytics. Sports-related injuries continue to rise due to changing lifestyles, and a growing interest in health and fitness. A higher demand for sports medicine also comes into play thanks to the world’s aging population and less-invasive arthroscopic surgery techniques. The greatest share of profit within sports medicine is derived from shoulder and knee treatments, with arthroscopic repairs marking the market segment with the fastest rate of growth. The US dominates the arthroscopic market, with Smith & Nephew remaining the leading company operating in the market. Other key companies include ArthroCare, Stryker, Conmed, DePuy Mitek and Arthrex.



Regional Market Share


  • The emerging nations of China, Russia, South Africa, Brazil and India hold immense potential for the general and specialty medical industry due to a significant number of patients whose needs are not currently being met. According to Global Data, there are over 120 million people aged 65 or older living in China. In India, more than a billion people, or 5% of the overall population, fall into this category. The country’s population is set to outpace that of China in around 20 years, which will make it the world’s most-densely populated nation. Healthcare demand is, therefore, set to continue rising at a high rate.


  • In Europe, facial aesthetics, medical laser devices and cosmetic surgery generated close to $660 million in 2010, according to research from iData Research. The market is expected to grow to $1.3 billion by 2017.



Market Outlook


Demand for both general and specialty medical treatments are set to continue rising due to an aging global population and rising cases of lifestyle-related diseases like diabetes and cardiac problems. The healthcare system is under immense pressure, made worse by the economic crisis. Due to budgetary cuts and reduced spending, some patients are delaying medical treatment and procedures. As the economy recovers and some patients benefit from wider health coverage, the number of specialty procedures carried out may be set to rise.



Leading Industry Associations offers immediate download access to top market reports & statistics on the General Medicine And Specialty Medicine Industry from trusted sources.
1-10 of about 12 000 reports

General Medicine And Specialty Medicine Markets in the US

  • March 2015
    24 pages
  • General Medicin  

  • United States  



View report >

General Medicine And Specialty Medicine Industry in Japan

  • February 2015
    7 pages
  • General Medicin  

    Heart Failure  


  • Japan  

View report >

General Medicine And Specialty Medicine Industry in Germany

  • February 2015
    12 pages
  • General Medicin  

  • Germany  

    United States  

View report >

General Medicine And Specialty Medicine Industry in Italy

  • January 2014
    14 pages
  • General Medicin  

  • Italy  

View report >

General Medicine And Specialty Medicine Industry in the UK

  • March 2015
    19 pages
  • Cancer  

  • United Kingdom  

View report >

General Medicine And Specialty Medicine Industry in Canada

  • January 2015
    20 pages
  • General Medicin  

  • Canada  

View report >

About 3 400 reports

Purchase Reports From Reputable Market Research Publishers
(From $ 55 - $ 7 995)

OpportunityAnalyzer: Acromegaly and Gigantism - Opportunity Analysis and Forecast to 2018

OpportunityAnalyzer: Acromegaly and Gigantism - Opportunity Analysis and Forecast to 2018

  • $ 7 995
  • Industry report
  • December 2014
  • by Global Data

OpportunityAnalyzer: Acromegaly and Gigantism - Opportunity Analysis and Forecast to 2018 Summary GlobalData estimates the 2013 sales for acromegaly and gigantism at approximately $588m across the 6MM ...

Frontier Pharma: Liver Cancer - Identifying And Commerc ...

December 2014 $ 6 995

Sports Medicine: Technologies And Global Markets

March 2015 $ 6 650

Therapeutics For ”silent” Cancers

February 2015 $ 6 650

Radiotherapy: Technologies And Global Markets

February 2015 $ 6 650

The Market For Minimally Invasive Medical Devices

January 2015 $ 6 650

Breast Cancer Diagnostic And Drug Technologies: Global ...

January 2015 $ 6 650

Analysis Of The Global Oncology Drug Delivery Market : ...

February 2015 $ 6 500

A Competitive Analysis Of The Global Breast Cancer Ther ...

March 2015 $ 5 000

A Product And Pipeline Analysis Of The Lung Cancer Ther ...

January 2015 $ 5 000

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.